We are live on ! Find out more
ARDS

Aridis Pharmaceuticals Inc. Common Stock
ARDS

Delisted

ARDS was delisted on the 18th of July, 2023.

Back to rankings

1 hedge funds and large institutions have $3 invested in Aridis Pharmaceuticals Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SFCL
Strengthening Families & Communities LLC
Massachusetts
+$3

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SFCL
1
Strengthening Families & Communities LLC
Massachusetts
$3 +$3 +3,000 New

ARDS Hedge Fund Activity: Q3 2025 in Review

1 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Aridis Pharmaceuticals Inc. Common Stock (ARDS) for Q3 2025, worth a combined $3.

Buyers outnumbered sellers: 1 fund opened new ARDS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Strengthening Families & Communities LLC, opening a new position worth an estimated $3.

  • 1 institutional investor held Aridis Pharmaceuticals Inc. Common Stock (ARDS) as of Q3 2025, up from 0 in Q2 2025.
  • Funds reported $3 of Aridis Pharmaceuticals Inc. Common Stock stock for Q3 2025.
  • 1 fund opened new Aridis Pharmaceuticals Inc. Common Stock positions in Q3 2025 and 0 closed out, a net change of +1 holder.
  • The largest Aridis Pharmaceuticals Inc. Common Stock buyer in Q3 2025 was Strengthening Families & Communities LLC, an estimated $3 added.

Based on aggregated 13F filings for Q3 2025.